会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Gel composition for treating mycosis
    • 用于治疗真菌病的凝胶组合物
    • US08889155B2
    • 2014-11-18
    • US12521483
    • 2007-12-28
    • Tomohiro OkumuraAkiko OchiaiKeizo SakudaYoshiyuki Tatsumi
    • Tomohiro OkumuraAkiko OchiaiKeizo SakudaYoshiyuki Tatsumi
    • A61K9/00A61K47/32A61K47/26A61K47/10A61K47/14A61K31/454A61K9/06
    • A61K31/454A61K9/0014A61K9/06A61K47/10A61K47/14A61K47/26A61K47/32
    • The present invention provides a stable gel composition for mycosis treatment, with increased absorption and permeation of (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin -1-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol into a target site (skin and nail). The gel composition for mycosis treatment, comprises (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl) -1-(1H-1,2,4-triazol-1-yl)-butan-2-ol or an acid addition salt thereof, a lower alcohol, a polyhydric alcohol and a gel-forming polymer. The gel composition of the present invention increases permeation of the above compound into a target site and into the nail. The gel composition of the present invention allows the drug to be directly and rapidly absorbed and permeated into a target site in a constant manner, for mycosis treatment, particularly onychomycosis treatment.
    • 本发明提供了用于真菌病治疗的稳定凝胶组合物,其中(2R,3R)-2-(2,4-二氟苯基)-3-(4-亚甲基哌啶-1-基)-1-(1H -1,2,4-三唑-1-基) - 丁-2-醇转化成靶位点(皮肤和指甲)。 用于真菌病治疗的凝胶组合物包含(2R,3R)-2-(2,4-二氟苯基)-3-(4-亚甲基哌啶-1-基)-1-(1H-1,2,4-三唑-1-基) - 丁基) - 丁-2-醇或其酸加成盐,低级醇,多元醇和凝胶形成聚合物。 本发明的凝胶组合物增加了上述化合物渗透到靶部位和钉子中。 本发明的凝胶组合物允许药物以恒定的方式直接且快速地吸收并渗透到靶位点,用于真菌病治疗,特别是甲真菌病治疗。
    • 3. 发明申请
    • GEL COMPOSITION FOR TREATING MYCOSIS
    • 用于治疗糖皮质激素的凝胶组合物
    • US20100317695A1
    • 2010-12-16
    • US12521483
    • 2007-12-28
    • Tomohiro OkumuraAkiko OchiaiKeizo SakudaYoshiyuki Tatsumi
    • Tomohiro OkumuraAkiko OchiaiKeizo SakudaYoshiyuki Tatsumi
    • A61K31/454A61P31/10
    • A61K31/454A61K9/0014A61K9/06A61K47/10A61K47/14A61K47/26A61K47/32
    • The present invention aims to provide a gel composition for mycosis treatment, which ensures good absorption and permeation of (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol into a target site (skin and nail). The present invention also aims to provide a gel composition for mycosis treatment, which is excellent in stability of this drug.It is a gel composition for mycosis treatment, which comprises (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol or an acid addition salt thereof, a lower alcohol, a polyhydric alcohol and a gel-forming polymer.The gel composition of the present invention is excellent in permeation of KP-103 into a target site and also excellent in permeation into the nail. Thus, the gel composition of the present invention allows the drug to be directly and rapidly absorbed and permeated into a target site in a constant manner, and thereby produces an excellent effect in mycosis treatment, particularly onychomycosis treatment.
    • 本发明旨在提供用于真菌病治疗的凝胶组合物,其确保(2R,3R)-2-(2,4-二氟苯基)-3-(4-亚甲基哌啶-1-基)-1- (1H-1,2,4-三唑-1-基) - 丁-2-醇转化成靶位点(皮肤和指甲)。 本发明的目的还在于提供一种用于真菌病治疗的凝胶组合物,该药物的稳定性优异。 它是用于真菌病治疗的凝胶组合物,其包含(2R,3R)-2-(2,4-二氟苯基)-3-(4-亚甲基哌啶-1-基)-1-(1H- 三唑-1-基) - 丁-2-醇或其酸加成盐,低级醇,多元醇和形成凝胶的聚合物。 本发明的凝胶组合物的KP-103在目标部位的渗透性优异,对于指甲的渗透性优异。 因此,本发明的凝胶组合物能够使药物以恒定的方式直接且快速地吸收并渗透到靶部位,从而在真菌病治疗,特别是甲真菌病治疗中产生优异的效果。